A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • In the media
  • Can Novartis really make its medicines availa...
Media - published on 04 Feb 2021
Share

Can Novartis really make its medicines available to everyone?

Writing for Swissinfo, Jessica Davis Plüss asks whether Switzerland-based Novartis's "experiment" to make its products widely available will succeed, citing the company's ranking in the 2021 Access to Medicine Index.

Next up: Media

GSK, Novartis, J&J and Pfizer lead pharma at making their meds accessible: report

Get in touch

Back to top |